Mission Pharmacal announced the launch of its grape-flavored Prednisolone Sodium Phosphate Oral Solution. Prednisolone Sodium Phosphate is a glucocorticoid indicated in the treatment of various steroid-responsive disorders, including severe asthma attacks in children.
This new oral solution comes in a higher 25mg/5mL strength, which means 40% less volume compared to the 15mg/5mL formula.
Prednisolone Sodium Phosphate Oral Solution will be available in a 25mg/5mL strength in 8oz bottles as early as April 2013.
For more information call (210) 696-8400 or visit www.prednisolone25.com.